Influence of N-methyl D-aspartate receptor mechanism on WIN55,212-2-induced amnesia in rat dorsal hippocampus

Behavioural Pharmacology

Volumn 22, Issue 7, 2011, Pages 645-654

  Jamali Raeufy, Nida ^a,b   Nasehi, Mohammad ^g   Zarrindast, Mohammad Reza ^a,c,d,e,f  

^a Institute for Cognitive Science Studies (ICSS)   (Iran)

^b Department of Physiology ^*  (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d School of Advanced Medical Technologies   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^g ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

hippocampus; MK801; N methyl D aspartate; rat; step through inhibitory avoidance task; WIN55,212 2

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL ROOT; DRUG EFFECT; HIPPOCAMPAL CA1 REGION; MALE; MEMORY; MICROINJECTION; NONHUMAN; RAT; TRAINING;

AMNESIA; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BENZOXAZINES; CANNABINOID RECEPTOR AGONISTS; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; MALE; MAZE LEARNING; MEMORY; MEMORY, SHORT-TERM; MORPHOLINES; NAPHTHALENES; NEUROPROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 80052942167     PISSN: 09558810     EISSN: 14735849     Source Type: Journal    
DOI: 10.1097/FBP.0b013e32834aff1f     Document Type: Article

References (72)

1. Ahmadi S, Zarrindast MR, Haeri-Rohani A, Rezayof A, Nouri M (2007). Nicotine improves morphine-induced impairment of memory: possible involvement of N-methyl-D-aspartate receptors in the nucleus accumbens. Develop Neuro-biol 67:1118-1127. (Pubitemid 47343753)
2. Ameri A (1999). The effects of cannabinoids on the brain. Prog Neurobiol 58:315-348. (Pubitemid 29230000)
3. Antonelli T, Tanganelli S, Tomasini MC, Finetti S, Trabace L, Steardo L, et al. (2004). Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5- methyl-3-(4-morpholinyl-methyl)pyrrolo[1,2,3-de]-1, 4-benzoxazin-6-yl]-1- naphthale-nylmethanone: an in vivo microdialysis study in the awake rat. Neuroscience 124:367-375. (Pubitemid 38229656)
4. Antonelli T, Tomasini MC, Tattoli M, Cassano T, Tanganelli S, Finetti S, et al. (2005). Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb Cortex 15:2013-2020. (Pubitemid 41628339)
5. Baratti SR, Kopf A (1996). A nitric oxide synthase inhibitor impairs memory storage in mice. Neurobiol Learn Mem 65:197-201.
6. Berrendero F, Maldonado R (2002). Involvement of the opioid system in the anxiolytic-like effects induced by delta(9)-tetrahydrocannabinol. Psychophar-macology (Berl) 163:111-117. (Pubitemid 34985320)
7. Bilkei-Gorzo A, Racz I, Valverde O, Otto M, Michel K, Sastre M, et al. (2005). Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc Natl Acad Sci USA 102:15670-15675. (Pubitemid 41528114)
8. Bliss TV, Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361:31-39. (Pubitemid 23020772)
9. Brusco A, Tagliaferro P, Saez T, Onaivi ES (2008). Postsynaptic localization of CB2 cannabinoid receptors in the rat hippocampus. Synapse (New York, NY) 62:944-949.
10. Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, et al. (2000). Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 396:141-149. (Pubitemid 30265571)
11. Chaperon F, Thiebot MH (1999). Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13:243-281. (Pubitemid 30265251)
12. Da Silva G, Takahashi RN (2002). SR 141716A prevents delta 9-tetrahydro-cannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuro-Psychoph Biol Psychiatr 26:321-325. (Pubitemid 34038061)
13. Davies SN, Pertwee RG, Riedel G (2002). Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42:993-1007. (Pubitemid 34786553)
14. De Oliveira Alvares L, Pasqualini Genro B, Diehl F, Quillfeldt JA (2008). Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms. Neurobiol Learn Mem 90:1-9.
15. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V (2001). The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276:12856-12863.
16. Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU, et al. (2006). Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 26:5794-5799. (Pubitemid 44315272)
17. Ferrari F, Ottani A, Vivoli R, Giuliani D (1999). Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task. Pharmacol Biochem Behav 64:555-561. (Pubitemid 29488485)
18. Flood JF, Fall SA, Uezu K, Morley JE (1998). The pharmacology of post-trial memory processing in septum. Eur J Pharmacol 350:31-38. (Pubitemid 28288305)
19. Fraga D, Zanoni CI, Rae GA, Parada CA, Souza GE (2009). Endogenous cannabinoids induce fever through the activation of CB1 receptors. Br J Pharmacol 157:1494-1501.
20. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. (2006). Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071:10-23. (Pubitemid 43255471)
21. Haller J, Varga B, Ledent C, Freund TF (2004). CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol 15:299-304. (Pubitemid 39062560)
22. Hampson RE, Deadwyler SA (1999). Cannabinoids, hippocampal function and memory. Life Sci 65:715-723. (Pubitemid 29362777)
23. Harrod SB, Flint RW, Riccio DC (2001). MK-801 induced retrieval, but not acquisition, deficits for passive avoidance conditioning. Pharmacol Biochem Behav 69:585-593. (Pubitemid 32758745)
24. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al. (1990). Cannabinoid receptor localization in brain. Proc Nat Acad Sci USA 87:1932-1936.
25. Hernandez-Tristan R, Arevalo C, Canals S, Leret ML (2000). The effects of acute treatment with delta 9-THC on exploratory behaviour and memory in the rat. J Physiol Biochem 56:17-24. (Pubitemid 30263740)
26. Hillard CJ, Manna S, Greenberg MJ, DiCamelli R, Ross RA, Stevenson LA, et al. (1999). Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). J Pharmacol Exp Ther 289: 1427-1433. (Pubitemid 29246674)
27. Hlinak Z, Krejci I (1995). Kynurenic acid and 5,7-dichlorokynurenic acids improve social and object recognition in male rats. Psychopharmacology (Berl) 120:463-469.
28. Izquierdo I, Dias RD (1983). Endogenous state-dependency:memory regulation by post-training and pre-testing administration of ACTH, beta-endorphin, adrenaline and tyramine. Braz J Med Biol Res 16:55-64.
29. Izquierdo I, Ferreira MB (1989). Diazepam prevents post-training drug effects related to state dependency, but not post-training memory facilitation by epinephrine. Behav Neural Biol 51:73-79. (Pubitemid 19031965)
30. Izquierdo I, McGaugh JL (1987). Retention impairment by posttraining epinephrine: role of state dependency and of endogenous opioid mechanisms. Behav Neurosci 101:778-781. (Pubitemid 18009672)
31. Izquierdo I, Medina JH (1995). Correlation between the pharmacology of long-term potentiation and the pharmacology of memory. Neurobiol Learn Mem 63:19-32.
32. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, et al. (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26:5628-5637. (Pubitemid 44315254)
33. Kawabe K, Yoshihara T, Ichitani Y, Iwasaki T (1998). Intrahippocampal D-cycloserine improves MK-801-induced memory deficits: radial-arm maze performance in rats. Brain Res 814:226-230. (Pubitemid 29023432)
34. Kelley BG, Thayer SA (2004). Anandamide transport inhibitor AM404 and structurally related compounds inhibit synaptic transmission between rat hippocampal neurons in culture independent of cannabinoid CB1 receptors. Eur J Pharmacol 496:33-39. (Pubitemid 39024313)
35. Kobilo T, Hazvi S, Dudai Y (2007). Role of cortical cannabinoid CB1 receptor in conditioned taste aversion memory. Eur J Neurosci 25:3417-3421. (Pubitemid 46872762)
36. Lichtman AH, Dimen KR, Martin BR (1995). Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharma-cology 119:282-290.
37. Mackie KN, Stella N (2006). Cannabinoid receptors and endocannabinoids: evidence for new players. The AAPS 8:298-306.
38. Martin BR (1986). Cellular effects of cannabinoids. Pharmacol Rev 38:45-74. (Pubitemid 16077325)
39. Martin M, Ledent C, Parmentier M, Maldonado R, Valverde O (2002). Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology 159:379-387. (Pubitemid 34143362)
40. Maurice T, Hiramatsu M, Itoh J, Kameyama T, Hasegawa T, Nabeshima T (1994). Behavioral evidence for a modulating role of s ligands in memory processes Attenuation of dizocilpine (MK-801)-induced amnesia. Brain Res 647:44-56. (Pubitemid 24154500)
41. Mereu G, Fa M, Ferraro L, Cagiano R, Antonelli T, Tattoli M, et al. (2003). Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc Natl Acad Sci USA 100:4915-4920. (Pubitemid 36457828)
42. Mirchandani GR, Leone P, Collins WF, During MJ (1994). Improved spatial learning by perfusion of NMDA in rat CA1 hippocampus. Soc Neurosci Abst 20:776.
43. Mishima K, Egashira N, Hirosawa N, Fujii M, Matsumoto Y, Iwasaki K, et al. (2001). Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats. Jpn J Pharmacol 87:297-308.
44. Misner DL, Sullivan JM (1999). Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons. J Neurosci 19:6795-6805. (Pubitemid 29380108)
45. Mondadori C,Weiskrantz L (1993). NMDA receptor blockers facilitate and impair learning via different mechanisms. Behav Neural Biol 60:205-210.
46. Myhrer T, Paulsen RE (1992). Memory dysfunction following disruption of glutamergic systems in the temporal region of the rat: effects of agonistic amino acids. Brain Res 599:345-352. (Pubitemid 23030234)
47. Nasehi M, Sahebgharani M, Haeri-Rohani A, Zarrindast MR (2009). Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats. Neurobiol Learn Mem 92:391-399.
48. Nasehi M, Piri M, Jamali-Raeufy N, Zarrindast MR (2010). Influence of intracerebral administration of NO agents in dorsal hippocampus (CA1) on cannabinoid state-dependent memory in the step-down passive avoidance test. Physiol Behav 100:297-304.
49. Netzeband JG, Conroy SM, Parsons KL, Gruol DL (1999). Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture. J Neurosci 19:8765-8777. (Pubitemid 30226698)
50. Nguyen PV, Abel T, Kandel ER (1994). Requirement of a critical period of transcription for induction of a late phase of LTP. Science (New York, NY) 265:1104-1107. (Pubitemid 24293080)
51. Ossowska K (1994). The role of excitatory amino acids in experimental models of Parkinson's disease. J Neural Transm Park Dis Dement Sect 8:39-71.
52. Patel S, Hillard CJ (2006). Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling. J Pharmacol Exp Ther 318:304-311.
53. Paxinos G, Watson C (2007). The rat brain in stereotaxic coordinates. 6th edition London, UK: Academic Press.
54. Pettit DA, Harrison MP, Olson JM, Spencer RF, Cabral GA (1998). Immunohis-tochemical localization of the neural cannabinoid receptor in rat brain. J Neurosci Res 51:391-402. (Pubitemid 28078470)
55. Robinson L, Goonawardena AV, Pertwee RG, Hampson RE, Riedel G (2007). The synthetic cannabinoid HU210 induces spatial memory deficits and suppresses hippocampal firing rate in rats. Br J Pharmacol 151: 688-700. (Pubitemid 47016297)
56. Roohbakhsh A, Moghaddam AH, Massoudi R, Zarrindast MR (2007). Role of dorsal hippocampal cannabinoid receptors and nitric oxide in anxiety like behaviours in rats using the elevated plus-maze test. Clin Exp Pharmacol Physiol 34:223-229. (Pubitemid 46148266)
57. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, et al. (2007). The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152:1092-1101. (Pubitemid 350166046)
58. Smith FL, Cichewicz D, Martin ZL, Welch SP (1998). The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol. Pharmacol Biochem Behav 60:559-566. (Pubitemid 28282699)
59. Stella N, Schweitzer P, Piomelli D (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388:773-778. (Pubitemid 27375156)
60. Teledgy G, Kokavszky R (1997). The role of nitric oxide in passive avoidance learning. Neuropharmacology 36:1583-1587. (Pubitemid 28085918)
61. Thorat SN, Bhargava HN (1994). Effects of NMDA receptor blockade and nitric oxide synthase inhibition on the acute and chronic actions of delta 9-tetrahydrocannabinol in mice. Brain Res 667:77-82.
62. Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R (2002). Behavioural and biochemical evidence for interactions between delta 9-tetrahydrocanna-binol and nicotine. Br J Pharmacol 135:564-578. (Pubitemid 34151189)
63. Varvel SA, Lichtman AH (2002). Evaluation of CB1 receptor knockout mice in the Morris water maze. J Pharmacol Exp Ther 301:915-924. (Pubitemid 34595080)
64. Varvel SA, Hamm RJ, Martin BR, Lichtman AH (2001). Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacol-ogy (Berl) 157:142-150. (Pubitemid 32802125)
65. Ward L, Manson SE, Abraham WC (1990). Effects of the NMDA antagonists CPP and MK-801 on radial arm maze performance in rats. Pharmacol Biochem Behav 35:785-790. (Pubitemid 20129975)
66. Wilson RI, Nicoll RA (2002). Endocannabinoid signaling in the brain. Science (New York, NY) 296:678-682.
67. Yamada K, Rice KC, Flippen-Anderson JL, Eissenstat MA, Ward SJ, Johnson MR, et al. (1996). (Aminoalkyl)indole isothiocyanates as potential electrophilic affinity ligands for the brain cannabinoid receptor. J Med Chem 39: 1967-1974. (Pubitemid 26163247)
68. Zarrindast MR, Jafari MR, Shafaghi B, Djahanguiri B (2004). Influence of potassium channel modulators on morphine state-dependent memory of passive avoidance. Behav Pharmacol 15:103-110. (Pubitemid 38582276)
69. Zarrindast MR, Farajzadeh Z, Rostami P, Rezayof A, Nourjah P (2005). Involvement of the ventral tegmental area (VTA) in morphine-induced memory retention in morphine-sensitized rats. Behav Brain Res 163:100-106. (Pubitemid 40991725)
70. Zarrindast MR, Kangarlu-Haghighi K, Khalilzadeh A, Fazli-Tabaei S (2006). Influence of intracerebroventricular administration of cannabinergic drugs on morphine state-dependent memory in the step-down passive avoidance test. Behav Pharmacol 17:231-237.
71. Zarrindast MR, Solati J, Oryan S, Parivar K (2008). Effect of intra-amygdala injection of nicotine and GABA receptor agents on anxiety-like behaviour in rats. Pharmacology 82:276-284.
72. Zarrindast MR, Dorrani M, Lachinani R, Rezayof A (2010). Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice. Neurosci Res 67:25-32.